Antitumor necrosis factor-α antibody-coupled gold nanorods as nanoprobes for molecular optoacoustic imaging in arthritis

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 3, 2012, Pages 346-354

  Fournelle, Marc ^a   Bost, Wolfgang ^a   Tarner, Ingo H ^b   Lehmberg, Tobias ^a   Weiß, Eike ^c   Lemor, Robert ^a   Dinser, Robert ^b  

^a FRAUNHOFER INSTITUTE FOR BIOMEDICAL ENGINEERING   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Kibero GmbH   (Germany)

Author keywords

Arthritis; Gold nanorods; Molecular imaging; Optoacoustic imaging; TNF

Indexed keywords

1064 NM; ABSORPTION MAXIMA; ANTI-TUMORS; ARTHRITIS; CLINICAL APPLICATION; COUPLING CHEMISTRY; FOCUSED ULTRASOUND; GOLD NANOROD; GOLD NANORODS; HEALTHY CONTROLS; IN-VIVO; MOLECULAR MARKER; NECROSIS FACTORS; OPTOACOUSTIC IMAGING; OPTOACOUSTIC SIGNALS; OVER-EXPRESSION; PULSED ND:YAG LASER; SPATIALLY RESOLVED;

MAMMALS; MOLECULAR IMAGING; NANORODS; NEODYMIUM; PATHOLOGY; PHOTOACOUSTIC EFFECT; PLASMONS; ULTRASONIC APPLICATIONS; ULTRASONIC PROPAGATION; ULTRASONIC SCATTERING; ULTRASONIC TRANSDUCERS;

ANTIBODIES;

CERTOLIZUMAB PEGOL; GOLD; INFLIXIMAB; NANOROD; TUMOR NECROSIS FACTOR ALPHA;

ABSORPTION SPECTROSCOPY; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMAGE ANALYSIS; INFLAMMATION; KNEE ARTHRITIS; MOLECULAR IMAGING; MOUSE; NANOPROBE; NEODYMIUM LASER; NONHUMAN; OUTCOME ASSESSMENT; PHOTOACOUSTICS; SIGNAL NOISE RATIO; ULTRASOUND TRANSDUCER;

ABSORPTION; ANIMALS; ANTIBODIES; ARTHRITIS; GOLD; IMAGING, THREE-DIMENSIONAL; MICE; MOLECULAR IMAGING; MOLECULAR PROBES; NANOTUBES; PHOTOACOUSTIC TECHNIQUES; SPECTRUM ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84860392196     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.06.020     Document Type: Article

References (34)

1. Alamanos Y., Drosos A.A. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005, 4:130-136.
2. Majithia V., Geraci S.A. Rheumatoid arthritis: diagnosis and management. Am J Med 2007, 120:936-939.
3. Scheel A.K., Hermann K.G.A., Ohrndorf S., Werner C., Schirmer C., Detert J., et al. Prospective 7-year follow-up imaging study comparing radiography, ultrasonography and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann Rheum Dis 2006, 65:595-600.
4. Xu M., Wang L.V. Photoacoustic imaging in biomedicine. Rev Sc Inst 2006, 77:041101.
5. Zhang H.F., Maslov K., Li M.L., Stoica G., Wang L.V. In vivo volumetric imaging of subcutaneous microvasculature by photoacoustic microscopy. Opt Express 2006, 14:9317-9323.
6. Agarwal A., Huang S.W., O'Donnell M., Day K.C., Day M., Kotov N., et al. Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging. J Appl Phys 2007, 102:064701.
7. Copland J.A., Eghtedari M., Popov V.L., Kotov N., Mamedova N., Motamedi M., et al. Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography. Mol Im Biol 2004, 6:341-349.
8. Wang Y., Xie X., Wang X., Ku G., Gill K.L., O'Neal D.P., et al. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett 2004, 4:1689-1692.
9. Eghtedari M., Oraevsky A., Copland J.A., Kotov N.A., Conjusteau A., Motamedi M. High Sensitivity of in vivo detecion of gold nanorods using a laser optoacoustic imaging system. Nano Lett 2007, 7:1914-1918.
10. Kim C., Cho E.C., Chen J., Song K.H., Au L., Favazza C., et al. In vivo molecular photoacoustic tomography of melanomas targeted by bio-conjugated gold nanocages. ACSNano 2010, 4:4559-4564.
11. Mienkina M.P., Friedrich C.S., Hensel K., Gerhardt N.C., Hofmann M.R., Schmitz G. Evaluation of ferucarbotran (resovist) as a photoacoustic contrast agent. Biomed Tech 2009, 54:83-88.
12. de la Zerda A., Zavaleta C., Keren S., Vaitjilingam S., Bodapati S., Liu Z., et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nature Nanotechnol 2008, 3:557-562.
13. Kim G., Huang S.W., Day K.C., O'Donnell M., Agayan R.R., Day M.A., et al. Indocyanine-green-embedded pebbles as a contrast agent for photoacoustic imaging. J Biomed Optics 2007, 12:044020.
14. Bohren C.F., Human D.R. Absorption and scattering of light by small particles 1983, Wiley, New York.
15. Brennan F.M., Maini R.N., Feldmann M. TNFa - a pivotal role in rheumatoid arthritis?. Brit J Rheum 1992, 31:293-298.
16. Nikoobakht B., El-Sayed M.A. Preparation and growth mechanism of gold nanorods using a seed-mediated growth method. Chem Mater 2003, 15:1957-1962.
17. Jana N.R., Gearheart L., Murphy C.J. Seed-mediated growth approach for shape-controlled synthesis of spheroidal and rod-like gold nanoparticles using a surfactant template. Adv Mat 2001, 13:1389.
18. Steinhauser I., Spänkuch B., Strebhardt K., Langer K. Trastuzumab-modied nanoparticles: Optimisation of preparation and uptake in cancer cells. Biomaterials 2006, 27:4975-4983.
19. Savino TM Safety considerations for pulsed lasers. Conformity 2002, October 20-27.
20. Rosloniec E.F., Cremer M., Kang A.H., Myers L.K., Brandt D.D. Collagen-induced arthritis. Curr Prot Immunol 2010, 89:15.5.1-15.5.25.
21. Li P.C., Wang C.R., Shieh D.B., Liao C.K., Poe C., Jhan S., et al. In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods. Opt Express 2008, 16:18605-18615.
22. Danscher G. Localisation of gold in biological tissue. A photochemical method for light and electronmicroscopy. Histochemistry 1981, 71:81-88.
23. Ding H., Yong K.T., Roy I., Pudavar H.E., Law W.C., Bergey E.J., et al. Gold nanorods coated with multilayer polyelectrolyte as contrast agents for multimodal imaging. J Phys Chem C 2007, 111:12552-12557.
24. Niidome T., Yamagata M., Okamoto Y., Akiyama Y., Takahashi H., Kawano T., et al. Peg-modified gold nanorods with a stealth character for in vivo applications. J Control Release 2006, 114:343-347.
25. Rengel Y., Ospelt C., Gay S. Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthr Res Ther 2007, 9:221.
26. Teng Y.K., Levarht E.W., Toes R.E., Huizinga T.W., van Laar J.M. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation. Ann Rheum Dis 2009, 68:1011-1016.
27. Wunder A., Tung C.H., Müller-Ladner U., Weissleder R., Mahmood U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004, 50:2459-2465.
28. Palframan R., Airey M., Moore A., Vugler A., Nesbitt A. Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis. J Immunol Methods 2009, 248:36-41.
29. Li M.L., Wang J.C., Schwarzt J.A., Gill-Sharp K.L., Stoica G., Wang L.V. In-vivo photoacoustic microscopy of nanoshell extravasation from solid tumor vasculature. J Biomed Opt 2009, 14:010507/1-3.
30. Kim K., Huang S.W., Ashkenazi S., O'Donnell M., Agarwal A., Kotov N.A., et al. Photoacoustic imaging of early inflammatory response using gold nanorods. Appl Phys Lett 2007, 90:223901.
31. Sachs D., Coelho F.M., Costa V.V., Lopes F., Pinho V., Amaral F.A., et al. Cooperative role of TNF-α, IL-1ß and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice. Br J Pharmacol 2010, 10.1111/j.1476-5381.2010.00895.x.
32. Böttger M.K., Hensellek S., Richter F., Gajda M., Stöckigt R., von Banchet G.S., et al. Antinociceptive effects of tumor necrosis factor alpha neutralisation in a rat model of antigen-induced arthritis. Arthritis Rheum 2008, 58:2368-2378.
33. Sandanaraj B.S., Gremlich H.U., Kneuer R., Dawson J., Wacha S. Fluorescent nanoprobes as a biomarker for increased vascular permeability: implications in diagnosis and treatment of cancer and inflammation. Bioconj Chem 2010, 21:93-101.
34. Hermann R., Schwarz H., Müller M. High precision immunoscanning electron microscopy using Fab fragments coupled to ultra-small gold. J Struct Biol 1991, 107:38-47.